JUVÉDERM ® VOLLURE ® XC injectable gel is for adults over 21. JUVÉDERM ® Ultra XC injectable gel is also for injection into the lips and perioral area for lip augmentation in adults over 21.

JUVÉDERM ® VOLLURE ® XC, JUVÉDERM ® Ultra Plus XC, and JUVÉDERM ® Ultra XC injectable gels are for injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, ...

JUVÉDERM® VOLUMA® XC for Moderate to Severe Temple Hollowing is Now Available Nationwide. Actual patient treated with 2.9 mL of JUVÉDERM® VOLUMA® XC in the temples, 2.1 mL of JUVÉDERM ...

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the national availability of JUVÉDERM® VOLUMA® XC for temple hollowing. Following its U.S. FDA approval in March 2024, JUVÉDERM® VOLUMA® ...

"The approval of JUVÉDERM ® VOLUMA ® XC to treat temple hollows further demonstrates Allergan Aesthetics commitment to innovation and addressing patient needs," said Carrie Strom, ...

The FDA has approved Juvéderm Voluma XC for the improvement of moderate to severe temple hollowing in the temple region in patients aged great than 21 years.

Allergan Aesthetics, an AbbVie company, announced that the FDA has approved Juvéderm Voluma XC to treat moderate to severe temple hollowing in adults over 21 years of age. According to the company, ...

JUVÉDERM® VOLLURE® XC injectable gel is for adults over 21. JUVÉDERM® Ultra XC injectable gel is also for injection into the lips and perioral area for lip augmentation in adults over 21.